ENTITY

Oncozenge (ONCOZ SF)

19
Analysis
Health Care • Sweden
OncoZenge AB (publ), a pharmaceutical company, engages in the a development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which is in Phase 3 clinical trials for the treatment of pain in the oral cavity. The company was incorporated in 2020 and is headquartered in Bromma, Sweden.
more
Filing Icon
No filings found
We’ll display filings we find for Oncozenge here
x